Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Chris Sale

The Trade That Started The Current Era Of White Sox Baseball

By | at

At the end of the 2016 season, the White Sox found themselves at a remove from recent success. They hadn’t posted a winning record since 2012 and hadn’t made the postseason since 2008. There was some talent on the roster but it was decided that it was time to hit the reset button. After much speculation, they gave a clear indication that they were going into a rebuild in December of 2016 when they traded left-hander Chris Sale to the Red Sox for prospects Yoán Moncada, Michael Kopech, Luis Alexander Basabe and Victor Diaz.

Sale was already well established as one of the better pitchers in the game. At the time of the trade, he had thrown 1110 innings with an even ERA of 3.00, striking out 27.9% of batters faced while walking just 5.8% and getting grounders at a solid 43.8% clip. The White Sox had signed him to an extension going into 2013, a deal that ran through 2017 but with two affordable club options after that. Flipping an excellent pitcher with three affordable years of control left little doubt that a significant teardown was beginning.

The trade worked out very well for the Red Sox, as they would make the postseason in two of those three years with Sale, including winning the World Series in 2018. They then signed him to another extension going into 2019, which is a separate matter. Injuries have largely prevented him from providing much value on that deal, but the trade still looks like a success. They gave up some future talent but saw Sale post a 2.90 ERA in 2017 and then a 2.11 in 2018 as they hoisted their fourth title in a span of 15 years after an 86-year drought.

For the Pale Hose, this was the first of several future-focused moves they would make around that time. The day after the Sale deal, they traded outfielder Adam Eaton to the Nationals for young pitchers Lucas Giolito, Reynaldo López and Dane Dunning. In July of 2017, they would send lefty José Quintana across town to the Cubs for a package headlined by prospects Dylan Cease and Eloy Jiménez. Many of the players involved in these deals would go on to form the core of the club as it returned to contention, alongside homegrown players like Tim Anderson and Luis Robert Jr..

The return on Sale needed to be huge, given his immense talent and three remaining years of cheap control. Indeed, the White Sox secured an incredibly significant prospect package, highlighted by Moncada. A high profile youngster out of Cuba, he signed with the Red Sox in March of 2015 for a $31.5MM bonus. This was back before the hard spending cap on international amateurs was put in place, but the Sox did have to pay a 100% tax because they had already exceeded their bonus pool figure, meaning they shelled out $63MM to get Moncada into the system.

He then played incredibly well in Single-A in 2015, hitting .278/.380/.438 for a wRC+ of 135. In 2016, he shot through High-A and Double-A and even made an eight-game debut in the majors. He struggled in that first taste of the show but was still just 21 years old at the time of the trade and was considered one of the top prospects in the league. Baseball America ranked him the #3 prospect in baseball going into 2016 and #2 in 2017.

Prospects with such high rankings are rarely traded, so it was a significant haul for the White Sox. The Red Sox likely have few regrets since Sale helped them to another title, but that wasn’t all Chicago got in return. Kopech was a notable prospect in his own right, having been selected in the first round of the 2014 draft. He had shown good form in the lower levels of the minors and was also on BA’s top 100 list, coming in at #89 in 2016 and was eventually placed #32 going into 2017. Basabe was a bit behind those two but was still an intriguing player, ranked Boston’s #9 prospect in 2016 and then Chicago’s #8 prospect going into 2017. Diaz was the least notable of the bunch but still cracked BA’s list of top White Sox farmhands after the deal, getting the #26 spot.

Moncada would scuffle a bit in his first two seasons in Chicago. Over 2017 and 2018, he walked in 10.9% of his trips to the plate but also struck out in 33% of them. He did hit 25 combined home runs over those two years but his .234/.321/.403 batting line amounted to a wRC+ of 99, a hair below league average. In 2019, he finally broke out and showed why he had been so touted as a prospect. He launched 25 more homers that year and slashed .315/.367/.548 for a wRC+ of 139. He was also graded well for his third base defense and stole 10 bases, leading to a tally of 5.5 wins above replacement from FanGraphs, making him one of the top 20 position players that year. 2020 was set to be his final year of club control, but the White Sox decided they believed in the breakout and committed to Moncada. The two sides agreed in March of 2020 to a $70MM extension that runs through 2024 and has a club option for 2025.

It’s been a bit of a mixed bag since that deal was inked. Moncada slumped a bit in the pandemic-shortened 2020 season but the club went 35-25 and qualified for the postseason for the first time since 2008. He was back on form in 2021, hitting just 14 home runs but walking at an excellent 13.6% rate. His .263/.375/.412 line translated to a 120 wRC+ and he continued to get good grades for his glovework, leading to a 4.0 fWAR season. The Sox went 93-69 and topped the American League Central, making the postseason in consecutive years for the first time in franchise history.

2022 was a frustrating season for both player and team. Moncada made trips to the injured list for an oblique strain, a right hamstring strain and then a left hamstring strain. He got into just 104 games and didn’t play up to his usual standard when on the field. He was one of many injuries that held the club back, as they finished 81-81 and failed to extend their postseason run into a third year. He roared out of the gates here in 2023, hitting .308/.325/.564 in nine games, but he’s been on the injured list for a few weeks now due to a protruding disc in his back that’s touching a nerve.

Though he’s been inconsistent, Moncada has shown the capacity to be an excellent player when everything is clicking and he’s been a key part of the club’s recent success. It’s hard to say the same for Kopech, however, as various circumstances have prevented him from reaching the heights that had previously been imagined for him. By the time the 2018 season rolled around, Kopech was considered by BA to be the #11 prospect in the league. That year, he thrived in Triple-A, posting a 3.70 ERA over 24 starts while striking out 31.3% of batters faced. He got called up to the majors in August but made just four starts before requiring Tommy John surgery, which wiped out the remainder of that season as well as his 2019. He then opted out of the 2020 pandemic season, returning to the club in 2021. Since he had missed two whole seasons, he was kept in relief that year. He fared well in that role, registering a 3.50 ERA in 69 1/3 innings, striking out 36.1% of batters faced.

He had built up a decent innings total that would allow him to return to the rotation in 2022, but the reins weren’t completely off. He made trips to the injured list for a knee strain and shoulder inflammation, tossing 119 1/3 innings on the year. He finished with a 3.54 ERA but a diminished 21.3% strikeout rate. A .223 batting average on balls in play likely helped him skate by, with his 4.50 FIP and 4.73 SIERA showing a bit less enthusiasm. He’s struggled out of the gates early here in 2023, with a 7.01 ERA after five starts.

As for the other two players in the deal, Basabe topped out at Double-A in the White Sox’ system before getting designated for assignment in 2020. He was then traded to the Giants, who gave him a nine-game MLB stint that year before outrighting him in the winter. He returned to the White Sox on a minor league deal last year but was released after a rough showing in just nine Triple-A games. Diaz pitched in the lower levels of the system in 2017 but injuries prevented him from getting into any official action after that. His transactions tracker indicates he was officially released in 2021.

It’s too early to completely close the book on the trade from Chicago’s perspective. Moncada is still under contract through 2024 and there’s the option for 2025. Kopech can still be retained via arbitration through 2025. There’s still time for things to change, but as of right now, the deal looks like a sort of microcosm of the club’s rebuild on the whole. There have been some good moments but it hasn’t quite been the runaway success that was envisioned. Moncada has had some good years but has been inconsistent and held back by injuries. Kopech has shown flashes of his talent but hasn’t really put it all together yet.

That semi-successful return in the deal has coincided with a semi-successful stretch of contention for the club, who made the playoffs twice recently but now seem at risk of seeing it fall apart. Their 8-21 record has them in a hole that they will have to crawl out of soon or else they’ll have to consider another selloff like the one they started over six years ago.

List Of Players On Track For 10-And-5 Rights

By | at

In baseball parlance, players are often said to have “10-and-5 rights” or the player might be described as a “10-and-5 guy.” Any player who has 10 or more years of service time and has been with his current club for five or more consecutive years gets veto power over any trade involving them. This essentially functions the same as a no-trade clause, which players can negotiate into their contracts. But with 10-and-5 rights, the right is gained automatically once the conditions are met. There is often overlap, as players that have no-trade clauses will eventually earn 10-and-5 rights as well, which makes it a moot point in those cases.

A player’s status as a 10-and-5 player can impact trade negotiations, as players like Adam Jones and Brandon Phillips have used it blocked trades in the past. Also, a team may sometimes trade a player on the cusp of reaching 10-and-5 status, since it becomes harder to line up a deal once the player has that veto power. The Rays traded Evan Longoria to the Giants in the 2017-2018 offseason, when his service time was at nine years and 170 days, meaning he would have earned 10-and-5 rights just two days into the 2018 campaign.

Listed below are the players who currently have 10-and-5 rights, as well as those who are approaching that mark. For instances where service time is mentioned, keep in mind that an MLB season has 187 days but a player’s service time “year” flips over at 172.

Currently Have 10-and-5 Rights

Altuve has over 11 years of service time and has spent it all with the Astros. It’s a fairly moot point as his current deal, which runs through 2024, contains a full no-trade clause. The club is also more likely to give him another extension than trade him.

Blackmon has over 10 years of service time and all of it with the Rockies. He triggered a player option for 2023, after which he will be a free agent.

Cabrera will reach 20 years of service this year and has been with the Tigers since 2008. He is in the final guaranteed year of his contract, with a couple of vesting options that aren’t a factor since he needs to finish in the top 10 in MVP voting the year prior in order to trigger them. He’s been fairly open about how he’s quite likely to retire at the end of the current season.

Crawford has over 11 years of service, all of it with the Giants. He’s slated for free agency at the end of this season.

Kershaw has over 14 years of experience at this point, all of it with the Dodgers. A trade wouldn’t seem plausible anyway, as he and the club seem to have a nice relationship with each other. He’s re-signed on one-year deals in each of the past two offseasons, seemingly keeping the door open to retirement whenever he decides it’s time.

Perez has spent his entire career with the Royals, which has pushed him past the 11-year mark in terms of service time. His current deal runs through 2025 with a club option for 2026.

Sale has gone beyond the 12-year service time mark and is now in his sixth season with the Red Sox. The extension he signed with the club in March of 2019 gave him a full no-trade clause in the middle of the 2020 campaign. He’s been floated as a speculative trade candidate if the Sox fall out of contention this year, though Sale would have to approve such a deal. His current contract runs through 2024 with a club option for 2025.

Stanton has over 12 years in the big leagues now and is in his sixth campaign as a Yankee. His deal runs through 2027 with a club option for 2028.

Strasburg has beyond 12 years of service right now, all of it with the Nationals. The club’s deal with the right-hander after their 2019 World Series victory went south immediately, as he’s tossed just over 30 innings since then and doesn’t seem near any kind of return. That contract has a full no-trade clause and runs through 2026.

Trout has more than 11 years of service and all of it with the Angels. He already had full no-trade protection from his current contract, which runs through 2030. Some have speculated that the club could look to move Trout and do a full rebuild if Shohei Ohtani departs in free agency after this year. If the Angels ever did consider such a plan, Trout would have to be okay with the destination.

Votto is over 15 years of service at this point, all of it with the Reds. He’s had full no-trade protection since signing his ten-year extension in April of 2012. That deal is now in its final guaranteed year, with the club having a $20MM option for 2024 that comes with a $7MM buyout.

Wainwright has over 17 years of major league service time, all of that with the Cardinals. He re-signed with the club for 2023 and has full no-trade protection from that deal. He is planning to retire after this season.

Will Gain 10-and-5 Rights This Year

Corbin already has over 10 years of service time and is currently in his fifth season with the Nationals. His six-year deal, which runs through 2024, contains partial no-trade protection but he will have 10-and-5 rights at the end of the 2023 campaign. The Nats would probably love to move him but he’s been getting worse in each year of the deal, with his ERA climbing from 3.25 in the first season to 4.66, 5.82 and 6.31, with his 2023 mark currently at 7.71. The backloaded deal will pay him $24MM this year and $35MM next year, meaning he would need a spectacular turnaround in order to have any trade appeal at all.

Goldschmidt has over 11 years of service time but only came over to the Cardinals for the 2019 season, making this his fifth year with the club. It’s a moot point since Goldy got a full no-trade in his most recent extension, which runs through 2024.

Harper has over 10 years of service already and is in his fifth season with the Phillies. His 13-year deal comes with full no-trade protection anyway, and it’s not like the Phils have any interest in trading him. The deal goes through 2031.

Hicks has been with the Yankees since 2016 and came into this season with his service time at 9.041. That means he’s slated to have 10-and-5 rights in August, just after the trade deadline. The extension he signed with the club in 2019 did not have any no-trade protection, though Hicks would get a $1MM assignment bonus if he were traded. He’s perhaps the most notable player on this list, given that he actually seemed like a viable trade candidate in the most recent offseason, though no deal has come together as of yet. His contract pays him $10.5MM this year and then $9.5MM in the next two years with a $12.5MM club option for 2026 with a $1MM buyout. If the Yanks want to get this deal off the books, they should probably do it in the next few months. Then again, Hicks has been pretty open about his frustrations with his reduced role of late, speaking to Brendan Kuty of The Athletic about it recently. Perhaps he wouldn’t mind a change of scenery that results in more playing time.

LeMahieu has already surpassed the 10-year service time mark and is in his fifth campaign as a Yankee. His current deal, which runs through 2026, affords him full no-trade protection already.

Machado has over 10 years of service and is in his fifth campaign as a Padre. He already has full no-trade via his contract, which runs through 2033.

Pressly has been with the Astros since July of 2018, meaning he’ll reach five years with the club this summer. He also came into the year with his service time at 9.039, meaning he’ll get to 10 years in August. Pressly has emerged as one of the best relievers in baseball during his time in Houston and has twice agreed to an extension with the club, so a trade doesn’t seem especially likely. His current deal goes through 2024 with a vesting option for 2025.

Yelich is in his sixth season as a Brewer and will get to 10 years of service this season, but it’s a moot point since he has a full no-trade clause in his extension, which runs through 2028 with a mutual option for 2029.

Could Gain 10-and-5 Under Current Contract

Acuna came into this season with just under five years of service time, meaning he won’t get to the 10-year mark until early in the 2028 season. His extension runs through 2026 with two club options. He’s one of the best players in the league and is underpaid on his deal, so Atlanta won’t be looking to deal him unless they fall way out of contention between now and then.

Albies has over five years of service and will get to 10 years in 2027. His extension goes through 2025 with a pair of club options. Similar to Acuna, he’s an excellent player who is on a club-friendly deal, meaning he won’t be a trade candidate unless something horrible happens to the team’s long-term fortunes.

Arenado will cross ten years of service here in 2023 but it’s only his third season as a Cardinal, meaning he’ll have 10-and-5 status after the 2025 season. That’s mostly just a footnote though, since Arenado’s extension with the Rockies came will full no-trade protection, which he waived to become a Cardinal. He seems quite content in St. Louis and chose not to opt-out of his deal at the end of 2022, even though he could have likely got more money on the open market.

Báez came into this season with his service at 7.089, meaning he’ll get to 10 years about halfway into the 2025 season. This is just his second year as a Tiger, meaning he’ll get to 10-and-5 status after 2026, when he will have one year left on his six-year deal. That contract affords Báez limited no-trade protection, which allows him to block trades to 10 teams each year, per Evan Petzold of the Detroit Free Press. Báez can also opt out after this year, though that doesn’t seem to be a strong possibility based on his performance as a Tiger thus far.

Berríos comes into this season with his service time at 6.044, which puts him in line to get to 10 years late in the 2026 season. He’ll also get to five years with the Blue Jays at the end of July in that year, since he was acquired from the Twins at the deadline in 2021. His extension, which runs through 2028, affords him an opt-out after that 2026 season and gives him an eight-team no-trade list, per Gregor Chisholm of The Toronto Star.

Betts has a service count of 8.070, meaning he’ll get to 10 years in the middle parts of next year. He’s been with the Dodgers since 2020, meaning he’ll get to 10-and-5 at the end of the 2024 season. Given his excellent production on a consistent competitor like the Dodgers, he doesn’t stand out as a trade candidate anyway, unless something changes drastically. His extension runs through 2032.

Bogaerts only just joined the Padres, but his 11-year deal means he’ll be a 10-and-5 guy after 2027. That doesn’t really matter since he has a full no-trade clause on his deal anyway, making it likely he’s a Padre through 2033.

Bryant is in just his second campaign as a Rockie but will be a 10-and-5 guy after 2026. He already has a full no-trade clause in his contract, which runs through 2028.

Buxton already has a full no-trade clause on the extension he and the Twins signed in November of 2021. He has between six and seven years of service time and will pass 10 years in 2026, with his deal running through 2028.

Castillo came into this season with his service time at 5.101, putting him in line to get to 10 years a couple of months into 2027. He’ll also get to the five-year mark with the Mariners midway through that season, having been acquired in July of 2022. His contract runs through 2027 with a vesting/club option for 2028. He has full no-trade protection on that deal but only for the first three years, which starts this year. That means his ability to block a trade will be gone at the end of the 2025 season but return in late July 2027.

Cole will get to 10 years of service here in 2023 but won’t have five years as a Yankee until the end of 2024. It’s a moot point anyway since his contract, which runs through 2028, gives him full no-trade protection. He can opt out after 2024 but the team can void that by triggering a club option for 2029.

Contreras has over six years of service time and will pass the 10-year mark in 2026. Since he just signed with the Cardinals, he won’t have five years with the club until the end of 2027. That will be the last guaranteed season of the five-year deal, though there’s a club option for 2028.

Correa will get to 10 years of service in 2025 but won’t have five years as a Twin until after 2026. His 10-and-5 status is a footnote anyway, since he has a full no-trade clause already.

Cronenworth has been with the Padres since the start of 2020, meaning he came into this year with exactly three years of service time. He won’t get to 10 years until the end of the 2029 campaign but he just signed an extension with the club that runs through 2030. He has an eight-team no-trade clause on that deal.

Darvish has over 11 years of service time now but won’t have five years as a Padre until after 2025. He recently signed an extension that runs through 2028, which affords him full no-trade protection.

deGrom only just joined the Rangers on a five-year deal, though there’s a conditional option for 2028. It’s a moot point anyway since he already has a full no-trade clause in the deal.

Devers came into this season with his service clock at 5.070, meaning he’ll get to the 10-year mark midway through 2027. His extension, which runs through 2033, does not give him any no-trade rights. It seems unlikely that the Sox would try to move Devers, since he seemed to be the one superstar they were intent on keeping while trading Betts and letting Bogaerts get away. But if something changes years down the road and they start considering a Devers deal, it would get harder after his 10-and-5 rights kick in.

Despite being on the injured list and likely to miss all of 2023, this will be the fifth season as a Met for Diaz. He’ll get to 10 years of service in 2026 but has full no-trade protection on his deal, which runs through 2027 with an option for 2028. He can opt out after 2025.

Flores will get to 10 years of service here in 2023 but won’t have five years as a Giant until after 2024. That’s the last guaranteed year of his extension, but there’s a dual option for 2025. Flores will have a $3.5MM player option and, if he declines, the club will have a $8.5MM option.

Freeland came into this year with a service count of 5.144, meaning he’ll get to 10 years early in 2027. His extension is only guaranteed through 2026, though there’s a $17MM player option for 2027, which is contingent on Freeland tossing 170 innings in 2026. The Rockies rarely trade their core players even when it’s fairly logical to do so, but it’s possible this could become noteworthy as the contract winds down.

Freeman already has over 12 years of service time but is in just his second season as a Dodger. He’ll have 10-and-5 rights after 2026, when his deal will have one year and $27MM remaining on it.

Franco came into 2023 with his service time at just 1.104, meaning he won’t get to 10 years until midway through 2031. His deal goes through 2032 with a club option for 2023. Most teams wouldn’t give much thought to trading a face-of-the-franchise player like Franco, but the Rays are always frugal and already went down this road once. As mentioned up top, they dealt Longoria just as his 10-and-5 rights were about to kick in. Franco doesn’t have any no-trade protection but would get an extra $3MM if he’s ever dealt.

Gimenez has just 2.106 as a service time count, but he just signed an extension that runs through 2029 with a club option for 2030. He’ll cross the 10-year service mark during that 2030 campaign.

Harris didn’t even play a full season last year but was awarded a full year of service time anyway by winning Rookie of the Year. He signed an eight-year extension with the club that runs through 2030 with a couple of club options after that. He’ll be a 10-and-5 guy at the end of the 2031 campaign if the first of those options is triggered.

Hayes comes into 2023 with his service clock at 2.075, putting him on a path to reach 10 years during the 2030 campaign. His deal with the Pirates is only guaranteed through 2029 but there’s a club option for 2030.

Hendricks had a service time count of 8.081 at the start of this season, meaning he’ll get to 10 years midway through 2024. This is the last guaranteed year of his extension, with a $16MM club option for 2024 with a $1.5MM buyout. Hendricks has struggled in the past two seasons and hasn’t yet pitched this year after suffering a capsular tear in his throwing shoulder last year. It seems unlikely that option gets picked up unless he gets healthy and has a tremendous showing in the second half of this year.

Judge has a full no-trade clause in his mega-deal with the Yankees, and it’s hard to fathom the club wanting to deal him anyway. He will get to 10 years of service time in 2026.

Lindor started this year with a service count of 7.113, meaning he will get to 10 years of service in 2025. That will also be his fifth year as a Met. He currently has a 15-team no-trade clause as part of his extension, which runs through 2031.

Marte has been with the Diamondbacks since 2017 and will surpass the 10-year service mark in 2026, with his service clock at 6.162 coming into this year. His extension runs through 2027 with a club option for 2028.

McCullers has spent his entire career as an Astro and will cross the 10-year threshold in 2025, coming into this year with a service tally of 7.140. The extension he signed with the club in 2021 runs through 2026 and has limited no-trade protection.

McMahon has been with the Rockies for his entire career with a service tally of 5.006 coming into this year. That puts him on pace to get to 10 years of service in 2027, the final year of the extension he recently signed with the club. He could potentially earn opt-out opportunities after 2025 and 2026 based on MVP voting.

Murphy came into this year with his service time at 3.029, meaning he won’t get to 10 years until 2029. His recent extension with Atlanta goes through 2028 with a club option for 2029.

Musgrove will get to 10 years of service time in 2026, which will be his sixth as a Padre. His extension, which runs through 2027, gives him a full no-trade clause through 2026. He only has limited no-trade protection in 2027 but he’ll be a 10-and-5 guy by then.

Nimmo has been a Met for his entire career and will get to the 10-year service mark in 2026, but he has a full no-trade clause on his contract anyway.

Olson has a service tally of just 5.103 and isn’t slated to cross the 10-year mark until 2027. His extension with Atlanta runs through 2029 with a club option for 2030.

Ozuna came into this season with his service clock at 9.124, meaning he’ll be at 10 years in May. However, this is just his fourth year with Atlanta, meaning he won’t be a 10-and-5 guy until after 2024. That’s the final guaranteed year of his deal, though there is a $16MM club option for 2025. It’s highly unlikely he’s still with the club at that time, since this deal is generally considered to be underwater both due to his poor performance and off-field issues. It’s already been speculated that the club may release him before the deal is finished, making it hard to envision a trade or the option eventually being picked up.

Ramírez has spent his entire career with Cleveland and will get to 10 years of service in 2024. It’s a moot point as his extension, which runs through 2028, has a full no-trade clause.

Realmuto is currently in his fifth year with the Phillies and had a service count of 8.038 coming into the year. That puts him on pace for 10-and-5 status towards the end of next year. His deal doesn’t have any no-trade protection, but he does get a $1MM bonus every time he’s dealt. He’s under contract through 2025, which will be his age-34 season.

Rendon will get to 10 years of service here in 2023 but it’s just his fourth season as an Angel. He’ll get to 10-and-5 status after 2024 but already has full no-trade protection on his contract, which runs through 2026.

Riley came into 2023 with a service count of 3.138, which puts him on track to pass 10 years early in 2029. His deal runs through 2032 with a club option for 2033.

Rodón will get to 10 years of service in 2025 and then have five years as a Yankee after 2027, when he’ll have one year left on his six-year deal. The 10-and-5 status will be irrelevant, however, as he already has full no-trade protection.

J-Rod has just the one year of service time so far but recently signed a convoluted mega-extension that could potentially end up lasting 18 years. He has full no-trade protection as part of that, making his eventual 10-and-5 status moot.

Ruiz had just 1.064 as a service count coming into this year but recently agreed to a lengthy extension with the Nats that runs through 2030 with two club options after that. He’s currently on pace for 10-and-5 rights in 2031.

Seager will get to 10 years of service in 2025 but won’t have five years as a Ranger until the end of 2026. He has limited no-trade protection on his deal, which runs through 2031.

Semien will get to 10 years of service in 2024 but won’t have five years in Texas until after 2026. He doesn’t have any no-trade protection on his deal, which runs through 2028.

Senzatela came into this year with a service tally of 5.106, putting him on pace to get to 10 years a few months into 2027. His extension with the Rockies is only guaranteed through 2026, but there’s a $14MM club option for 2027.

Springer will get to 10 years of service early in 2024 but is in just his third season as a Blue Jay right now. His six-year deal runs through 2026 and he’ll get 10-and-5 status after 2025. He currently has an eight-team no-trade clause.

Story will get to 10 years of service after 2025 but won’t have five years with Boston until after 2026. His deal, which runs through 2027, does not have any no-trade protection. He can opt out after 2025, but the team can void that by preemptively exercising an option for 2028.

Swanson only just joined the Cubs on a seven-year deal. By the end of 2027, he’ll have five years with the club and be well beyond 10 years of service, though it’s a moot point since he already has full no-trade protection.

Tatis has between three and four years of service, putting him on track for 10-and-5 in 2029, but he already has full no-trade protection on his extension which runs through 2034.

Taylor came into this year with a service count of 7.037, putting him on pace to get to 10 years late in the 2025 season. He’s already been with the Dodgers since partway through the 2016 campaign. His contract is guaranteed through 2025 with a club option for 2026. He doesn’t currently have any no-trade protection, but he does get a $2MM assignment bonus each time he’s dealt, and a trade would also increase the value of his option.

Turner just joined the Phillies but will get to 10-and-5 status after 2027. Like many others on the list, that designation doesn’t really matter for him, since his 11-year deal already affords him full no-trade protection.

The Volatile Red Sox Rotation

By | at

The Red Sox have been one of the more capricious teams in recent history. This millenium has seen them win the World Series four times but also finish fifth in the American League East five times. The past five seasons have seen them go from winning it all in 2018 to missing the playoffs in 2019, falling to last in 2020, back to the playoffs in 2021 but then back to the basement last year.

That mercurial nature seems to be embodied in this year’s rotation. There’s plenty of talent but also plenty of risk. It wouldn’t be a total shock to see this group be completely dominant or an utter disaster. Let’s take a look at the candidates and their respective error bars.

Chris Sale

From 2012 to 2018, Sale was one of the best pitchers in the league. He tossed 1,388 innings over that stretch with a 2.91 ERA, 30.2% strikeout rate, 5.4% walk rate and 42.7% ground ball rate. His 39.2 fWAR in that period was bested only by Clayton Kershaw and Max Scherzer.

Unfortunately, that’s starting to feel like ancient history now. Sale struggled in 2019 with a 4.40 ERA over 25 starts. That was the “juiced ball” season and his 19.5% HR/FB rate was a career high, so perhaps it wasn’t as bad as it seemed, but ERA estimators still pointed to him taking a step back from his previous work. The three subsequent seasons have been mostly lost to injuries, with Sale undergoing Tommy John surgery in March of 2020. He returned in 2021 and made nine starts that year, but then the injury bug came back the next season. A right rib stress fracture put him on the injured list to start the year, and then he was hit by a comebacker when he returned and suffered a left fifth finger fracture. While on the IL with that finger injury, he fractured his right wrist in a bicycle accident.

Some of those injuries are of the fluky variety and don’t necessarily point to any irreversible core issue. However, Sale will turn 34 years old in March and has pitched less than 50 major league innings in the past three years, including just 5 2/3 last year. It’s difficult to know what to expect from him after so little recent work, and even if he’s in good form, will he eventually hit some kind of wall? Either mandated by the club or just a physical limit?

James Paxton

Paxton is in a fairly similar situation to Sale, though his previous highs aren’t quite as high. From 2016 to 2019, he posted a 3.60 ERA over 568 innings. He struck out 28.5% of batters he faced while walking just 6.7% and got grounders at a 42.6% clip. His 15.1 fWAR in that period was 12th among all pitchers in the league. But various arm injuries have limited him to just six starts since then, with his last in April of 2021. He required Tommy John at that time and was on his way back last year but suffered a lat tear during his rehab.

The Sox could have locked him in for another two seasons by triggering a $26MM option but made the obvious choice to turn that down. Paxton then turned down a chance to return to free agency by triggering his $4MM player option for this year. Like Sale, he’s coming off three mostly lost seasons and will be 34 this year, but he’ll be almost two years removed from his last major league appearance once the season begins. Will he be able to get things back on track and, if so, for how long?

Corey Kluber

Kluber’s arc has some echoes of the two guys already mentioned in this piece, though with more optimistic developments recently. From 2014 to 2018, he made 160 starts with a 2.85 ERA, 28.5% strikeout rate, 5.2% walk rate and 44.8% ground ball rate. His 30.3 fWAR just nudged out Sale and trailed only Scherzer and Kershaw.

But after that, a forearm fracture and teres major muscle tear limited him to just eight starts over 2019 and 2020. He got back on track somewhat in 2021, as a shoulder strain sent him to the IL for about three months, but he still made 16 starts with a 3.83 ERA. He stayed healthy enough to take the ball 31 times last year, posting a 4.34 ERA. That came with excellent control as he walked just 3% of batters, but his strikeouts were down to a 20.2% clip.

Those past couple of seasons are encouraging but Kluber turns 37 in April. His fastball averaged 88.9 mph last year, well down from his 94-95 mph peak form. He seems like he has the ability to succeed despite that diminished stuff, but that will likely become more challenging over time, even if he does stay healthy.

Nick Pivetta

Compared to the three previous pitchers on this list, Pivetta is the picture of reliability. He hasn’t been to the injured list for a non-COVID reason during his time in the majors, which began in 2017.

However, that might be his best asset, as he hasn’t exactly wowed with the results. He has a 5.02 ERA for his career and registered a 4.56 mark last year. His 22.6% strikeout rate was slightly better than that of the average starter last year, but his 9.4% walk rate and 38.5% ground ball rate were both a few points worse. He’s not terribly exciting but there’s certainly value to that kind of steadiness, especially amid this erratic group.

Garrett Whitlock

Whitlock had a great season in 2021 after being plucked from the Yankees in the Rule 5 draft. He tossed 73 1/3 innings over 46 relief appearances with a 1.96 ERA, 27.2% strikeout rate, 5.7% walk rate and 49.7% ground ball rate. He began 2022 back in the bullpen but the Sox tried stretching him out midseason. He made nine starts before a hip issue sent him to the injured list in June. He returned in July but was kept in a relief role until the hip issue put him on the IL again in September. He underwent surgery for that hip at that time but is expected to be ready for spring.

The club plans on implementing him as a starter here in 2023, which will be an interesting experiment. The 120 2/3 innings he threw in the minors in 2018 are the most in a single season on his résumé, as he’s been in the 70-80 range since then. With just those nine big league starts to his name, can he suddenly jump to a full starter’s workload? And even if he can, will he be able to maintain the same quality of of work that he did in relief in 2021-22?

Tanner Houck

Houck is in a fairly similar boat to Whitlock, as there are intriguing results there but it’s tough to map out the best path forward. He has a 3.02 ERA in 146 innings for his career thus far, striking out 27.6% of batters faced, walking 8.7% and getting grounders at a 49.3% rate. That work has involved 20 starts and 33 relief appearances. The splits aren’t huge, as he has a 3.22 ERA as a starter and a 2.68 out of the ’pen. He dealt with lingering back issues last year that sent him to the injured list in August and he ultimately underwent surgery in September.

The club has indicated they may stretch Houck out as a starter in camp but move him to the bullpen if the five guys ahead of him are all healthy. That still leaves a decent chance of him spending some time in the rotation this year. He made just four starts last year and hasn’t reached 120 innings in any of his professional seasons.

Brayan Bello/Kutter Crawford/Josh Winckowski

These three all have made their major league debuts but likely need more time to develop. Bello registered a 4.71 ERA last year, with Crawford at 5.47 and Winckowski at 5.89. They all have options and might be in the minors to start the year. But given the unstable nature of the arms ahead of them on the depth chart, there’s a chance they will be needed at some point.

Brandon Walter/Bryan Mata/Chris Murphy

These three are all on the 40-man but have yet to reach the majors. Walter and Murphy just got added in November to protect them from the Rule 5 draft. Walter has just nine Double-A starts and two at Triple-A, meaning he likely won’t be lined up for his debut in the immediate future. Murphy made 15 Triple-A starts last year but put up a 5.50 ERA in that time. Mata underwent Tommy John in April of 2021 and was able to return last year and toss 83 innings in the minors, but he has just five Triple-A starts to his name thus far. This group could be called upon if things really go south, but they will likely be behind the Bello/Crawford/Winckowski trio unless things shift as the season progresses.

_____

As mentioned off the top, there’s plenty of talent here but there are so many ways this could play out. Five years ago, Sale, Paxton and Kluber would have been a dominant front three but the odds of them all suddenly clicking into their previous ace levels are low. Whitlock and Houck have had tantalizing results but each is coming off a season ended by surgery and both are generally unproven as starters over any kind of meaningful stretch. The younger depth options could always take a step forward and seize a job but they probably can’t be counted on yet.

It seems the error bars are quite wide for the Sox going into 2023. Center field and shortstop will be manned by players with minimal experience at those positions in Adam Duvall and Enrique Hernández, respectively. Their first baseman will be Triston Casas, who has 27 MLB games to his name. Their left fielder will be Masataka Yoshida, attempting to make the transition from NPB to MLB. They’re hoping to get some kind of contribution from Adalberto Mondesi, who’s been limited to just 50 games over the past two years combined. There’s uncertainty all over the place, including the rotation. In a style that fits the organization, they could have a miracle season or it could all go horribly wrong.

AL East Notes: Guerrero, Sale, Rays

By | at

Vladimir Guerrero Jr. and the Blue Jays “haven’t had the conversations yet” this winter about a multi-year extension, the slugger tells Sportsnet’s Shi Davidi and other reporters.  Guerrero didn’t sound overly concerned about the lack of talks, saying “I’m going to stay focused on working hard and let my team take care of that.”  The idea of a long-term deal between Guerrero and the Jays has been a topic essentially since Guerrero arrived in the majors as baseball’s top prospect, and though the first baseman is heading into his fifth MLB season, the clock isn’t yet ticking too loudly on Guerrero’s team control.  Toronto still has arbitration control over Guerrero through the 2025 season, and the two sides already worked out a contract for Guerrero for 2023, as he’ll earn $14.5MM for the coming year.

With Guerrero set to become a free agent prior to his age-27 season, this relatively early entry into the market likely means a particularly large payday is awaiting the first baseman — whether from another team, or in the form of an extension from the Blue Jays to lock Guerrero up as the face of the franchise.  As Davidi notes, the massive longer-term contracts handed out this winter undoubtedly caught the attention of both the Jays and Guerrero’s representatives, and now both sides may have a better view of what it might cost the Blue Jays to retain Guerrero’s services.  Since most extension talks usually don’t begin until deeper into Spring Training, it will be interesting to watch if Guerrero and the Jays have any substantive negotiations, or if any real progress is made towards an extension.

More from the AL East…

  • After three injury-riddled seasons, Chris Sale told reporters (including The Boston Globe’s Peter Abraham) that he is “very, very excited” about being healthy and heading for his first normal Spring Training since 2019.  Between a Tommy John surgery, a fractured rib, and fractures to his finger and wrist, Sale has pitched only 48 1/3 Major League innings since the start of the 2020 season, which was also the first season of a five-year, $145MM contract extension Sale had signed with the Red Sox the year prior.  Given the lack of return on this extension, Sale feels “I owe my teammates the starting pitcher they thought they were going to get.  I owe the front office the starting pitcher they paid for.  I owe the fans performances they’re paying to come and see.”  Looking for a silver lining to his injury woes, Sale noted “that’s three years of [pitching] that’s not on my arm” as he enters his age-34 season.  “That’s not going on the odometer.  I’ve kept myself in really good physical shape.  My arm’s feeling good.  I don’t have any hesitation going forward with pitching.”
  • Seven Rays players are slated for arbitration hearings, which is (as per MLB.com) is the third-highest number of hearings for any team in the history of the arb process.  President of baseball operations Erik Neander felt the lack of agreement in negotiations with the seven prior to the arbitration filing deadline were “much more about the uniqueness of several players’ career paths leading to a bit of a more challenging experience for both parties to find common ground,” the executive told Marc Topkin of the Tampa Bay Times.  “But I very much believe that everyone worked to find it — we just didn’t quite get there.”  As Topkin notes, the differences between the Rays’ submitted salary figures and the seven players’ figures work out to only $2.85MM in total.  That said, it doesn’t seem likely that any deals will be worked out before the sides present their cases to an arbiter, unless a player signs a multi-year contract.  [RELATED: the full list of the 33 players who are heading for arbitration hearings]

Red Sox Notes: Middle Infield, Hernandez, Arroyo, Sale, Whitlock, Houck

By | at

Red Sox’s brass met with reporters and fans at their Winter Weekend convention this evening. Manager Alex Cora and chief baseball officer Chaim Bloom each addressed the roster status with roughly two months remaining in the offseason.

The middle infield is among the biggest questions. With Xander Bogaerts in San Diego and Trevor Story set to miss at least a notable portion of the upcoming season, Boston has very little certainty up the middle. Adam Duvall agreed to a one-year deal earlier this week to man center field, likely kicking Enrique Hernández back to the infield.

Manager Alex Cora suggested that was currently the team’s plan, implying that Hernández was the in-house favorite to play shortstop (via Ian Browne of MLB.com). That leaves Christian Arroyo as the likeliest option to man second base. Bloom indicated the team remained open to adding help from outside the organization (relayed by Julian McWilliams of the Boston Globe) but the Hernández – Arroyo pairing seemingly has the inside track among internal candidates.

Hernández has experience at every non-catching position on the diamond. He’s primarily played center field or second base, logging just 618 shortstop innings through parts of nine MLB seasons. Defensive Runs Saved has looked favorably upon his limited work there, rating him as nine runs better than average overall. Hernández has typically graded out as a solid or better second baseman and a particularly strong center fielder, where he spent the bulk of his time in 2022.

Arroyo has been in the Boston second base mix for the past couple seasons. He’s hit at a roughly league average level in both years, making plenty of contact to compensate for low walk rates. Arroyo has logged just under 900 major league innings at the keystone. Defensive Runs Saved has pegged him an excellent 10 runs better than the average defender there, while Statcast has rated him as an exactly average gloveman.

There aren’t many middle infield options remaining in free agency. Elvis Andrus and Josh Harrison are probably the top players still available. The Sox have been loosely tied to both in recent days. Donovan Solano, César Hernández and José Iglesias are among the depth types remaining as well.

There’s also a fair amount of uncertainty on the pitching side of things in Fenway, largely thanks to injury. Chris Sale, Tanner Houck and Garrett Whitlock each ended the 2022 season on the injured list. Whitlock is returning from hip surgery, while Houck underwent a back procedure. Sale had myriad health concerns that culminated in surgery to repair a fracture in his right wrist sustained in a bicycle accident.

Cora said this evening that all three pitchers have been throwing off a mound (relayed by Jen McCaffrey of the Athletic). All three could factor into the rotation. Sale’s a lock for the starting five if healthy. The Sox have already announced they plan to give Whitlock a rotation opportunity. Houck’s role seems more fluid, as he could crack the starting five or remain in a high-leverage relief capacity. The former first-round pick has been the subject of some recent trade speculation, though there’s no indication a deal is on the horizon or especially likely to transpire.

Red Sox’s Chris Sale Drawing Trade Interest

By | at

Teams are reportedly checking in with the Red Sox on the availability of seven-time All-Star Chris Sale, per Jon Heyman of The New York Post. However, Heyman notes that Boston is “not looking to trade any of their starters,” but is “willing to listen and consider.” Sale is currently owed $55MM through the 2024 season. Nevertheless, Sale has full veto power over any potential trade by virtue of his 10-and-5 rights (ten years of Major League service time, including at least the past five with the same team).

Arriving in Boston after the 2016 season, Sale continued to display his superiority on the mound, pitching to sub-3 ERAs in 2017 and 2018 while helping the Red Sox win their fourth World Series Championship since 2000. Following their victory, Boston and Sale soon hammered out a five-year, $145MM extension (with a vesting option for the 2025 season) that many believed to be a bargain at the time for a starting pitcher that had seven consecutive All-Star appearances, six consecutive Top-5 Cy Young finishes, four consecutive seasons of MVP consideration, and boasted a career 2.89 ERA in 1482 1/3 innings with a 30.2 SO%,  5.7% BB, and 42.9% ground ball rate.

However, after signing that extension Sale went on to have arguably the worst full season of his career. In 2019, the southpaw saw his ERA balloon to a career-high 4.40 in 147 1/3 innings while dealing with inflammation in his pitching elbow that forced a premature end to his year.

After rehabilitation and undergoing a platelet-rich plasma injection, expectations were high for the lefty as the extension went into effect for the 2020 season. However, Sale would soon be forced to undergo Tommy John surgery in March 2020, missing the entirety of the truncated season and the first half of the 2021 season. He was then shelved for the beginning of the 2022 season due to a stress reaction in his ribcage, and he suffered a broken pinkie finger upon being hit by a comebacker shortly after returning. Then, shortly before he was scheduled to return to the club, the Red Sox announced in early August that Sale had fractured his wrist in a bicycle accident and would miss the remainder of the season.

Altogether, it’s been a near-nightmarish start to the contract extension for the Red Sox, although this year’s slate of injuries, in particular, seem fluky in nature. To Sale’s credit, in the small amount of time he’s been healthy enough to take the mound during the first three years of the extension, he’s been excellent. In those 48 1/3 innings, Sale owns a 3.17 ERA with a strong 27.4%% strikeout rate against a tidy 6.3% walk rate. Inning-for-inning, that’s largely the type of performance the Sox were hoping for — but Sale’s body has not held up.

The 33-year-old Sale (34 in March) is but one of many question marks for the Boston rotation. Nick Pivetta is the only largely established starting option for the Sox heading into 2023. Top prospect Brayan Bello is tentatively lined up for a turn in the rotation but didn’t quite seize one in this year’s rookie effort (57 1/3 innings, 4.71 ERA — albeit with better secondary marks and sparks of brilliance). Righties Garrett Whitlock and Tanner Houck have rotation potential but both have thus far been shuttled between the starting staff and the bullpen. Additional righty starters Kutter Crawford, Josh Winckowski, and Connor Seabold were all posted ERAs north of 5.25 as rookies in 2022.

With Nathan Eovaldi, Michael Wacha, and Rich Hill departing via free agency and Sale and James Paxton (also returning from injury) wild cards, the Red Sox were expected to target starting pitching this offseason. Nevertheless, the club has yet to add to their staff, instead fortifying their bullpen and adding position players Masataka Yoshida and Justin Turner.

From a financial perspective, if Sale, who is projected to be healthy for Spring Training, can return to even a fraction of his dominant self, the Red Sox will have control of a top-tier starting pitcher who can be considered ’cheap’ when compared to other high-level starters that have recently signed large contracts with AAVs greater than $35MM, such as Justin Verlander, Max Scherzer, Gerrit Cole, and Jacob deGrom. That’s not to say that Sale is currently at the level of those pitchers, but that he has been at similar heights and could reasonably reach a prominent level of production again

Currently, Roster Resource projects Boston’s payroll to be near $177MM, and their competitive balance tax figure to be roughly $203MM. With the base competitive balance tax threshold set at $233MM for the 2023 season, the Red Sox are in no rush to shed salary and may instead hold onto Sale in the hopes that he returns to his pre-Tommy John levels of excellence.

Chris Sale Will Not Exercise Opt-Out Clause

By | at

In one of the least-surprising opt-out decisions in recent memory, left-hander Chris Sale has informed the Red Sox that he will not exercise the opt-out clause in his five-year, $145MM contract, chief baseball officer Chaim Bloom tells Alex Speier of the Boston Globe.

There’s never been any real thought that Sale was a candidate to opt out of the remaining two years and $55MM on that ill-fated extension. He pitched just 5 2/3 innings with the Sox this season and, over the first three years of the agreement, has tallied just 48 1/3 innings through 11 starts. Sale underwent Tommy John surgery in March of 2020 and thus missed the entirety of that year’s truncated season.

The recovery from that Tommy John procedure sidelined him into August of 2021, and his 2022 season was derailed by a series of bizarre injuries; Sale was shelved for the beginning of the 2022 season due to a stress reaction in his ribcage, and he suffered a broken pinkie finger upon being hit by a comebacker shortly after returning. The Red Sox announced in early August that Sale had fractured his wrist in a bicycle accident and would miss the remainder of the season.

It’s been a nightmare start to the contract extension for the Red Sox, although this year’s slate of injuries, in particular, seem fluky in nature. To Sale’s credit, in the small amount of time he’s been healthy enough to take the mound during the first three years of the extension, he’s been excellent. In those 48 1/3 innings, Sale owns a 3.17 ERA with a strong 27.4%% strikeout rate against a tidy 6.3% walk rate. Inning-for-inning, that’s largely the type of performance the Sox were hoping for — but Sale’s body has not held up.

Looking ahead, the Sox have little choice but to hope Sale can get healthy and finally reclaim a spot near the front of their rotation. The lefty’s contract has zero trade value at present, and even if it did, Sale has full veto power over any potential trade by virtue of his 10-and-5 rights (ten years of Major League service time, including at least the past five with the same team).

The 33-year-old Sale (34 in March) is but one of many question marks for the Boston rotation. Nick Pivetta is the only largely established starting option for the Sox heading into 2023. Top prospect Brayan Bello could vie for a spot but didn’t quite seize one in this year’s rookie effort (57 1/3 innings, 4.71 ERA — albeit with better secondary marks). Righty Garrett Whitlock has obvious rotation potential but has thus far been shuttled between the starting staff and the bullpen. Fellow righties Kutter Crawford, Josh Winckowski and Connor Seabold were all hit hard as rookies in 2022.

Suffice it to say, with Nathan Eovaldi, Michael Wacha and Rich Hill all set to become free agents and Sale more or less a complete question mark, starting pitching will be one of the main focuses for the Red Sox this offseason. It won’t be their sole pursuit, however, as the Sox also potentially stand to lose Xander Bogaerts to free agency and still hope to extend slugger Rafael Devers, who is set to reach the open market following the 2023 campaign.

Including Sale’s weighty salary, the Sox have $86.72MM committed to next year’s books, although that’s counting a $20MM salary for Bogaerts, who is certain to opt out of his contract’s final three seasons. Boston also has nearly $40MM in projected arbitration salaries and is on the hook for some hefty contractual buyouts — most notably the $8MM yet owed to the since-released Jackie Bradley Jr. They’ll quite possibly be on the hook for James Paxton’s $4MM player option, which he’ll have the ability to exercise once the Sox make the easy call to decline his two-year, $26MM club option.

Previewing Upcoming Opt-Out Decisions And Player Options

By | at

With the offseason approaching, so is the time for players and teams to decide upon any 2023 options in their contracts. MLBTR has taken a look through various option decisions in recent weeks: first with players whose deals contain vesting provisions, then a respective look at the team options in both the American and National Leagues.

Today, we’ll turn our attention to the players’ side. A number of players could hit free agency this winter either by triggering an opt-out clause in their current deal or bypassing a player option for the 2023 campaign. We’ll take a run through those decisions, many of which will have implications at the very top of the free agent market.

Note: All stats referenced are through play Sunday

Elite Potential Free Agents

  • Nolan Arenado, Cardinals 3B (can opt out of final five years and $144MM)

Arenado was already on a Hall of Fame trajectory before 2022, but he’s bolstering his case with the best season of his career. Through 500 plate appearances, he owns a .306/.370/.567 line with 27 home runs. He’s had seasons with that kind of slash line in years past, but they came with the caveat that he’d played half his games at Coors Field. That’s no longer a factor, and it’s easily his best offensive output once one adjusts for the ballpark. Arenado’s 162 wRC+ is the fourth-best mark among qualified hitters.

That kind of offensive production alone would get him in the MVP discussion, but Arenado’s obviously valuable for far more than his bat. One of the best defensive third basemen in MLB history, he’s continued to post elite marks with the glove even as he’s entered his 30s. Arenado is among the top handful of players in the game. While walking away from $144MM wouldn’t be an easy decision, it’d seem the prudent one from a strict financial perspective. Freddie Freeman received six years and $162MM from the Dodgers (albeit with deferrals that reduced the net present value closer to the $148MM range) headed into his age-32 season. Freeman was coming off a 135 wRC+ platform showing, and he plays a less valuable position. Arenado and his camp could make a strong argument the Freeman contract should represent his floor, and it’s not outlandish to seek a six-year deal at the $35MM annual range Anthony Rendon received from the Angels (which would bring the guarantee to $210MM).

On paper, Arenado’s opt-out decision looks like a slam dunk. There’s at least some amount of uncertainty, though, as he forewent an opt-out opportunity last offseason and told Derrick Goold of the Post-Dispatch it was “always the plan” to remain in St. Louis long term. Passing on free agency coming off a .255/.312/.494 showing in 2021 is a lot easier than doing so after a career-best year that should make him an MVP finalist. Maybe he’s comfortable enough with the Cardinals he’ll return, but he’d probably be leaving a lot of money on the table to do so. At the very least, he looks to have a case for a renegotiation of his contract with the Cards, which is slated to pay him just $15MM in the final season (2027).

  • Carlos Correa, Twins SS (can opt out of final two years and $70.2MM this offseason; deal also contains post-2023 opt-out if Correa opts in this winter)

Regarded by many (MLBTR included) as the top free agent in last winter’s class, Correa reportedly turned down at least one ten-year offer early in the offseason in search of a guarantee that rivaled the $341MM Francisco Lindor had received from the Mets last April. That proposal seemingly never came, and Correa reversed course in Spring Training. He signed a shocking three-year deal with the Twins that guaranteed him the largest annual salary ($35.1MM) for a free agent position player and afforded the opportunity to retest the market in either of the next two offseasons via opt-out.

Conventional wisdom was that Correa was sure to trigger his first opt-out and make another run at a long-term deal in a winter unaffected by a lockout. That still seems likely, although he hasn’t resoundingly made the case for teams to be more willing to approach the Lindor range that they had been. He’s having a similar offensive season as he did during his final year with the Astros. After posting a .279/.366/.485 showing his last year in Houston, Correa is hitting .276/.355/.439 over 440 plate appearances with Minnesota. His raw power production is down, but that’s not quite as alarming when considering the leaguewide slugging percentage has dropped from .411 to .395. Perhaps of greater concern is that the elite defensive marks that garnered Correa a Gold Glove last season are unanimously down, ranging anywhere from below-average (-2 Outs Above Average) to solid (+4 Defensive Runs Saved, +1 Ultimate Zone Rating).

There’s no question Correa’s an excellent player having a very good season. Yet he’s not likely to wind up a top five finisher in MVP balloting as he did in 2021. He’d top a $200MM guarantee on the open market, but he’s unlikely to reach the kind of money he anticipated last offseason. Could he return to Minnesota (where he’s by all accounts very happy) for one more year and look to trigger his post-2023 opt-out after hopefully putting up MVP-caliber numbers? That feels unlikely, but he’s already bet on himself once and would only be entering his age-29 season if he put off opting out for a year.

Bogaerts has been the Red Sox’s everyday shortstop since 2014, but his time in Boston could be nearing its end. He and the club didn’t make progress in extension talks this spring, and he’s a lock to opt out and top $60MM on the open market barring a catastrophic injury. One of the game’s top offensive shortstops, Bogaerts is amidst another strong season. He carries a .303/.372/.448 line through 508 plate appearances. His slugging output is below where it was from 2018-21, but he consistently gets on base and has a strong pre-2022 track record from a power perspective.

One can quibble about certain aspects of Boagerts’ profile. In addition to this year’s slugging dip, he’s traditionally rated as a below-average defender. Even with generally solid defensive metrics this season, clubs will probably have some question whether he’ll eventually need to move to second or third base. Those are nitpicks for whether Bogaerts would be a worthwhile investment in the $180MM – $200MM range, though. A 30-year-old shortstop with an elite durability track record and a .299/.370/.478 line since the start of 2020, he’s certainly going to shatter $60MM even if the market takes a relatively pessimistic view of his long-term projection.

  • Jacob deGrom, Mets RHP (can opt of final year and $33.5MM this offseason)

There’s no suspense with this one, as deGrom has publicly maintained his plan to opt out for months. That’s in spite of elbow/shoulder injuries that kept him from throwing a major league pitch between July 2021 and this August. With only one guaranteed year remaining on his deal (plus a 2024 club option that’d go into effect if he doesn’t opt out this winter), that’s been a pretty easy call. To the extent there may have been any lingering doubts, deGrom has silenced them with his first five starts since returning from the injured list. He’s looked like his vintage self, averaging 99.3 MPH on his fastball while posting a laughable 46:2 strikeout-to-walk ratio through 29 1/3 innings. On an inning-for-inning basis, he’s the best starting pitcher on the planet.

deGrom’s free agent case will be fascinating. Even if he finishes the season healthy, he’ll have gone three consecutive years without topping 15 starts or 100 innings (although he’s obviously not at fault for the shortened 2020 schedule). What kind of volume a signing team can expect is an open question, particularly as he enters his age-35 season. Yet the upside of a healthy deGrom is through the roof. He’ll receive a multi-year deal that beats the $33.5MM remaining on his current contract. Can he top teammate Max Scherzer’s $43.333MM AAV over a three or even four-year term? Time will tell.

While we’re on the topic of upper-echelon starting pitchers who are basically certain to opt out, let’s turn to Verlander. The future Hall of Famer triggered a $25MM option for next season by throwing 130 innings, but that’s largely a moot point. Verlander told Ken Rosenthal of the Athletic last week he was likely to opt out if things went as planned down the stretch. It’d have been surprising if he were even considering exercising the option.

Verlander has returned from 2020 Tommy John surgery to lead the major leagues with a 1.84 ERA. He’s striking out 26.5% of opponents and has a strong argument for a third career Cy Young award. He’s also a proven playoff performer and a prototypical ace who eats about as many innings as anyone else in the game. Even heading into his age-40 season, Verlander can try to beat the Scherzer AAV on a multi-year contract.

Verlander did injure his calf in his most recent start, resulting in a placement on the injured list just this afternoon. The Astros announced that an MRI of his calf revealed “fascial disruption, but no muscle fiber disruption” — an extremely specific diagnosis but one that both Verlander and GM James Click touted as good news. Click expressed hope the injury will be short-term, and Verlander suggested that had he sustained damage to the muscle fibers themselves, he’d likely have missed the remainder of the regular season and perhaps part of the postseason.

The manner to which Verlander rebounds will obviously be key in his opt-out scenario, but if he misses only a couple weeks’ time and returns strong for his final regular-season and postseason starts, this opt-out is an easy call.

We’ll wrap up the trifecta with Rodón, who’s also going to have an easy decision, barring injury. While there was some trepidation about Rodón’s breakout 2021 season — both due to his inconsistent track record before last season and some shoulder soreness and a velocity drop last August — he’s doubled down and looks to have cemented himself among the game’s top ten starters. Rodón has avoided the injured list thus far, and he’s striking out 32.1% of opponents while posting a 2.81 ERA through 25 starts. By topping 110 innings, he earned the right to opt out after this season.

Heading into his age-30 campaign, he should land the nine-figure deal that eluded him last offseason. Between his youth and last two years of production, Rodón has an argument for the largest guarantee of any free agent starter. He won’t get paid at the deGrom or Verlander level on an annual basis, but he could push for six years and look to top $150MM.

Quality Regulars Likely To Opt Out

Rizzo’s market last offseason seemed a bit underwhelming. The veteran first baseman was coming off two fine but unspectacular seasons, and it looked as if his best days might be behind him with his mid-30s approaching. Rizzo still made plenty of contact and hit the ball hard, but he’d gotten quite pull-oriented and had rough ball-in-play results against an increasing number of defensive shifts. He signed a two-year deal with the Yankees that paid him matching $16MM salaries and allowed him to opt out after this season.

That now looks like an easy call, as Rizzo has bounced back with a year more reminiscent of his peak days with the Cubs. He carries a .223/.337/.480 line and is going to top 30 homers for the first time since 2017. He’s still getting dismal results on balls in play and doesn’t have a particularly impressive batting average, but even that looks as if might turn around next year. It’s widely expected MLB will institute limits on shifting next spring. Few players would stand to benefit more than Rizzo, who’s facing a shift on a whopping 83.5% of his plate appearances according to Statcast. His age and lack of defensive versatility will limit the length of any deal, but he’ll probably beat the $16MM salary over at least a two-year term, even if the Yankees tag him with a qualifying offer.

The Padres’ signing Profar to a three-year, $21MM deal that allowed him multiple opt-out chances was one of the more eyebrow-raising moves of the 2020-21 offseason. The switch-hitter was coming off a solid 2020 campaign, but that shortened schedule was the first in which he’d posted above-average production. It looked like a misstep when he struggled last year and unsurprisingly forewent his first opt-out clause, but Profar has rewarded the organization’s faith with a career-best showing in 2022.

Through 530 plate appearances, he’s hitting .241/.339/.387 with 12 homers. He’s walking at a robust 12.3% clip while only going down on strikes 15.1% of the time. He looks like a solid regular, and headed into his age-30 season, Profar’s a candidate for another multi-year deal this time around. After major throwing issues as an infielder early in his career, he’s played exclusively left field this year. Profar isn’t a prototypical corner outfield masher, but his plate discipline and bat-to-ball skills should allow him to top the guaranteed money remaining on his current deal.

Starting Pitchers With High Buyouts

Walker signed a $20MM guarantee with the Mets over the 2020-21 offseason. The deal was front-loaded but came with a $6MM player option or a $3MM buyout for 2023. Adding a player option allowed the Mets to soften the contract’s luxury tax hit. Because player options are treated as guaranteed money, it technically qualified as a three-year, $20MM deal with a $6.67MM average annual value for CBT purposes. Yet the $3MM gap between the option value and the buyout meant Walker was a virtual lock to opt out, barring injury that made him unable to pitch next season. The Associated Press reports the option has various escalators that could push its value as high as $8.5MM if Walker throws 175 innings this year, but even that figure is modest enough he’s going to decline.

Walker should opt out in search of a multi-year deal, as he’s been a valuable mid-rotation arm for New York. Over 117 1/3 frames, he owns a 3.38 ERA despite a modest 18.3% strikeout rate. His blend of plus control and solid ground-ball rates makes him a candidate for a three-year pact as he heads into his age-30 season. The Mets will have an interesting decision on whether to tag him with a qualifying offer.

Like Walker, Odorizzi signed late in the 2020-21 offseason on a deal that locked in the first two seasons and gave the player a third-year option. Odorizzi’s contract with the Astros was similarly structured to facilitate a third-year buyout while diminishing the AAV for luxury tax purposes, although he’s deciding on a bit more money. The option was initially valued at $6.5MM with a $3.25MM buyout, but the Associated Press provided a breakdown of various escalators. The option value would jump by $2MM apiece if Odorizzi reached 20, 25 and 30 appearances between 2021-22 in which he either started the game or worked four-plus innings of relief. The buyout value would spike by $1MM apiece for hitting each of those thresholds.

Odorizzi has already made 41 such appearances over the past two years, so he’s long since maxed out both thresholds. He’ll therefore be deciding between a $12.5MM option to return to the Braves or taking a $6.25MM buyout and heading to free agency. With only a $6.25MM difference between the option value and the buyout, Odorizzi looks like a borderline opt-out case. He owns a 3.90 ERA across 85 1/3 innings this season, although his 18.3% strikeout rate is a few points below league average. He’ll be 33 by next Opening Day, and he didn’t find as robust interest as most expected he would during his last trip through free agency. He’s a quality strike-thrower and a perfectly fine back-of-the-rotation starter, but it’s now been three years since he’s missed bats at an above-average rate, and he was traded this summer in a one-for-one swap for an underperforming reliever (Will Smith).

Easy Calls To Return

  • Chris Sale, Red Sox LHP (can opt out of final two years and $55MM)

Sale has the right to pass on the final two years of his extension with the Red Sox this winter, but he certainly won’t do so. He’s made just 11 starts over the past three seasons due to various injuries, including a 2020 Tommy John surgery and a trio of fractures (rib, finger and wrist) this year. Sale has still flashed mid-rotation or better upside in the limited time he’s been on the field, but there’s too much uncertainty with his health to land anywhere near $55MM were he to test the market.

  • Eric Hosmer, Red Sox 1B (can opt out of final three years and $39MM)

Hosmer’s opt-in decision is a no-brainer. Since signing a $144MM contract with the Padres heading into 2018, he’s posted a league average .264/.325/.409 slash line. Paired with his lack of defensive versatility and mixed reviews on his glovework (public metrics have never been as fond of Hosmer as his four Gold Gloves would suggest), he’d probably be limited to one-year offers were he a free agent. The Padres will remain on the hook for virtually all of the money, as they agreed to pay down Hosmer’s deal to the league minimum salary to facilitate his trade to the Red Sox.

  • Jorge Soler, Marlins LF (can opt out of final two years and $24MM; deal also contains post-2023 opt-out if Soler opts in this year)

Soler parlayed a big second half and huge batted ball metrics into a three-year deal with Miami last offseason. His massive raw power hasn’t translated into especially strong results since he’s become a Marlin, however. He’s been a below-average hitter, and it’s now been three years since he was a middle-of-the-order caliber player over a full season. Paired with a limited defensive profile that keeps him in the corner outfield or at designated hitter, he’s been right around replacement level this season. He’s not opting out this year, but a big showing in 2023 could allow him to reconsider the possibility next winter.

  • AJ Pollock, White Sox LF ($11MM option, $5MM buyout)

The White Sox acquired Pollock just before the start of the season, sending Craig Kimbrel to the Dodgers in a surprising one-for-one swap. The hope was that they’d addressed a notable hole in the corner outfield, but Pollock’s production has cratered in Chicago. Just a season removed from a .297/.355/.536 showing in L.A., he’s stumbled to a .237/.284/.363 line through 401 plate appearances with the ChiSox. Even with a fairly modest $6MM gap between the option’s present value and the buyout, Pollock is likely to bypass a trip to free agency after a replacement-level platform season.

The present $11MM option value isn’t fixed, as Pollock’s contract contains escalators that could boost it a bit further. Originally set at $10MM, he’d lock in an extra $1MM for hitting each of 400, 450, 500, 550 and 600 plate appearances this season. He’s already surpassed 400 trips, and the 450 mark is well within range with 34 games remaining. Consistent playing time down the stretch would allow him to reach 500 plate appearances as well, although it’s hard to envision him getting to 550. The most likely outcome is that the option price ends up at $12MM, but anywhere between $11-13MM is viable.

Schoop signed a two-year, $15MM extension amidst a productive 2021 season in Detroit. While a defensible enough decision for the Tigers at the time, that hasn’t panned out. The veteran second baseman has a .235 on-base percentage that’s easily the worst in the majors among players with 400+ plate appearances. He’s posted otherworldly defensive marks this season and could well collect a Gold Glove, but the complete lack of production at the dish should make him a lock to exercise his option.

Blackmon exercised a 2022 option last season, and he went on the record at the time as saying he’d trigger the 2023 provision as well. There’s no intrigue as to his decision — he’ll be back in Colorado next year — the only question is how much he’ll make. The ’23 option came with a $10MM base value, but ESPN reported it’d escalate by $500K apiece if Blackmon reached 400, 425, 450, 475, 500, and 525 plate appearances in 2022. It’d jump another $1MM apiece at 550 and 575 trips.

The veteran outfielder enters play Tuesday with 490 plate appearances, so he’s already pushed the value to $12MM. Barring injury, he’s a lock to hit at least the 525 PA mark, and he’s quite likely to get all the way to 575. Colorado has 33 games remaining, and Blackmon is only 85 plate appearances (2.76 per game) from maxing out the plate appearance threshold at $15MM. The deal also contained escalators based on MVP finishes which Blackmon will not hit.

Relievers

  • Nick Martinez, Padres RHP (can opt out of final three years and $19.5MM this offseason, $1.5MM buyout; deal also contains opt-out chances after 2023 and 2024 if Martinez opts in)

Martinez signed a four-year, $25.5MM guarantee with San Diego this past winter. That deal contained opt-out chances after each of the first three seasons for the former NPB hurler, but it seems unlikely Martinez will take his first opportunity to return to the open market. He has a strong 3.02 ERA over 92 1/3 innings during his return season in the big leagues, but he’s worked as a swingman for a San Diego team that has quite a bit of rotation depth. Martinez has excelled as a reliever, pitching to a 1.35 ERA while holding opponents to a .208/.258/.295 line in 40 innings. That’s come with a modest 21.5% strikeout rate, though, and he doesn’t brandish the power arsenal teams tend to prioritize late in games.

Entering his age-32 season, Martinez probably wouldn’t find a better deal that the opt-out laden three years and $18MM (after factoring in the buyout price) he’d be bypassing to return to the open market. The Friars have to be happy with their investment considering his excellence out of the bullpen, but the surprisingly strong deal they gave him in the first place makes it hard to see him doing much better elsewhere even on the heels of a quality first season.

Detroit signed the ever-reliable Chafin late last offseason, and they’ve been rewarded with another excellent year. Through 43 1/3 innings, he’s posted a 2.91 ERA while striking out more than 30% of opponents with an excellent 52.3% ground-ball rate. The market probably undervalued Chafin last winter; it’d be hard to do so again after another very good season. In a vacuum, declining the option and topping $6.5MM in free agency seems likely.

That said, the Tigers decision to not trade Chafin at this summer’s deadline was tied to a belief he could stick around. Evan Petzold of the Detroit Free-Press reported shortly before the deadline that Detroit’s proximity to Chafin’s Ohio home could lead him to return in 2023 if he weren’t moved before August 2. That led to a disconnect in his trade value, with the Tigers confident they still possessed a year and a half of his services while other clubs viewed him as an impending free agent. From a strict financial perspective, opting out is the prudent call. Yet the family considerations Petzold noted would make the decision more complicated if Chafin’s priority isn’t simply to maximize his earnings.

San Diego added Suárez, who’d never previously pitched in the majors, on the heels of an excellent career closing in Japan. He had a nightmare outing on Opening Day where he dished out free passes to all three batters he faced, but he’s been quite effective since that point. Excluding his first appearance, Suárez owns a 2.36 ERA with a strong 29% strikeout rate in 34 1/3 innings. He’s still had spotty control, but he’s averaging north of 97 MPH on his fastball. He’d only need to beat $4MM on the open market, and something around that rate over a multi-year term feels attainable heading into his age-32 season. A rough final couple months could change the calculus, but Suárez seems likely to retest free agency at the moment.

Red Sox Select Jeurys Familia

By | at

Just a few days after signing Jeurys Familia to a minor league contract, the Red Sox have selected the veteran right-hander to the big league roster.  In corresponding moves, right-hander Kaleb Ort was optioned to Triple-A, and Chris Sale (who recently underwent season-ending wrist surgery) was moved to the 60-day injured list.

Familia is looking for a new beginning after posting a 6.09 ERA over 34 innings with the Phillies this season.  Philadelphia signed the righty to a one-year, $6MM this past offseason, but ended up releasing Familia last week.  In signing Familia and promoting him to the MLB roster, the Red Sox now owe him just the prorated portion of the minimum salary, while the Phils are responsible for the remainder of that $6MM total.

It’s been a rough season for Familia, who has posted below-average walk and strikeout rates while allowing more hard contact than almost any pitcher in baseball.  Familia is still averaging 95.7mph on his fastball, but that has been the only one of his pitches that has still been effective, as per Statcast’s metrics.  Batters have been teeing off on Familia’s sinker, which has been his primary pitch for the majority of his career (and he still throws the sinker over 50 percent of the time).

Still, at least a couple of Familia’s metrics are more favorable, as his 3.91 SIERA and an eye-popping .408 BABIP indicate some level of bad luck, despite all of that hard contact.  There isn’t much risk for the Red Sox in seeing if Familia can still contribute at the big league level, or at least provide a fresh arm within what has been a pretty middling Boston relief corps.

Red Sox Notes: Paxton, Wacha, Houck, Sale

By | at

Red Sox lefty James Paxton, who underwent Tommy John surgery last year, seems to finally be healthy enough to start ramping things up. Chris Cotillo of MassLive reports that the southpaw recently faced lived hitters and is expected to throw in a simulated game this Friday. The next step after that will be for him to start a rehab assignment, which would be followed by a return to the big league club.

“He’s in such a good spot now that it’s not about the arm,” manager Alex Cora said about Paxton. “It’s about the pitch mix, the breaking ball, all that. When those guys start talking about that, you know they’re over the hump.”

Paxton’s form down the stretch will be very significant both for him and the club, regardless of where they are in the standings. Boston signed him to a unique contract over the offseason, knowing that he was rehabbing from TJS and unlikely to contribute over a full season. Paxton is making a $6MM salary this year and then the club will have to decide whether or not to trigger two $13MM options for 2023-2024 at the end of the season. If the team declines to pick up what is effectively a two-year, $26MM deal, Paxton can decide to trigger a $4MM player option for 2023 or decline it and return to free agency. Those decisions will surely depend upon what Paxton shows in the coming weeks.

The Red Sox could use some contributions from Paxton, both in this season and in the future, given the tumult of their rotation. Just about every starter in Boston’s rotation has either landed on the IL or been optioned to the minors at some point, with Nick Pivetta being the only constant. Michael Wacha has only made 13 starts this year due to a pair of IL stints, one for an intercostal strain and the other for shoulder inflammation. However, Cotillo reports that he threw 4 1/3 innings in a rehab start last night and should return to the big league club for his next outing. That should give the club a boost, as they look to finish strong in the AL Wild Card race. They are currently five games behind the Rays for the last spot.

Looking farther into the future, each of Wacha, Nathan Eovaldi and Rich Hill are slated to reach free agency this offseason, which is part of the reason why those Paxton options might seem alluring, even if he only returns for a brief period of time. The 2023 Boston rotation might also take a hit from the uncertainty surrounding Chris Sale. The lefty was once one of the most dominant arms in the game but has hardly pitched in recent years due to a cavalcade of injuries. Tommy John surgery wiped out his 2020 and limited him to nine starts last year. He began this year on the IL due to a stress fracture in rib cage, returning to throw one five-inning start before his second start was cut short after less than an inning when a comebacker broke his finger. While on the IL, he managed to get hurt again, falling off a bicycle near his home and breaking his wrist, eliminating any hopes of his return this year.

Due to all that, Sale will go into the offseason having thrown just 48 1/3 total innings over the past three seasons, which raises questions about how much the Red Sox can rely on him for the rotation next year. “We obviously need to think through what that means as far as planning out a full season with him not having carried very much of a workload the last few years,” chief baseball officer Chaim Bloom tells Jen McCaffrey of The Athletic. “If we want to play 162-plus we have to build our team to have a lot of starting pitching depth,” he added. With Hill, Wacha and Eovaldi headed to the open market and Sale and Paxton unknown wild cards at this point, there’s plenty of uncertainty hanging over Boston’s future rotation.

Turning back to the present season, the Sox placed reliever Tanner Houck on the 15-day injured list with back inflammation yesterday, Cotillo relays, which will deliver a hit to the bullpen. Houck has a 3.15 ERA on the year, with a 22.7% strikeout rate, 8.9% walk rate and 50.9% ground ball rate. That’s included many high-leverage spots, as Houck as eight saves and one hold on the year. He’ll join Tyler Danish, Matt Strahm and Josh Taylor among Boston relievers currently on the injured list. The bullpen is so banged up that Cora told reporters, including Alex Speier of the Boston Globe, that Hill might see some action out of the ’pen, despite having just started yesterday’s game.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top